ARTICLE | Company News
Celsis, Promega sales and marketing update
February 16, 2009 8:00 AM UTC
Promega will co-market its bioluminescent ADME-Tox assays with cryopreserved plateable hepatocytes from Celsis' Celsis In Vitro Technologies division. Celsis will pre-qualify lots of cryoplateable hep...